YARW (Yarrow Bioscience) Days Payable: 0.00 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

YARW Yarrow Bioscience Inc YARW
13 GF Score
Price $26.22
View Full Analysis

What is Yarrow Bioscience Days Payable?

Yarrow Bioscience YARW -2.78% 13 Days Payable is 0.00 as of Jun. 2026. GuruFocus rates YARW with a GF Score™ of 13/100. Among 707 Biotechnology companies, Yarrow Bioscience ranks worse than 141442.57% on this metric.

Yarrow Bioscience's average Accounts Payable for the three months ended in Jun. 2026 was $0.76 Mil. Yarrow Bioscience's Cost of Goods Sold for the three months ended in Jun. 2026 was $0.00 Mil.

The historical rank and industry rank for Yarrow Bioscience's Days Payable or its related term are showing as below:

YARW's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 111.24
* Ranked among companies with meaningful Days Payable only.

Yarrow Bioscience's Days Payable stayed the same from . 20 (0.00) to Jun. 2026 (0.00). stayed the same

Yarrow Bioscience Days Payable Historical Data

* Premium members only.

The historical data trend for Yarrow Bioscience's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yarrow Bioscience Days Payable Chart

Yarrow Bioscience Annual Data
Trend Dec25
Days Payable
0.00

Yarrow Bioscience Quarterly Data
Jun25 Dec25 Mar26 Jun26
Days Payable 0.00 0.00 0.00 0.00

YARW vs CGTX, RANI, VRCA: Days Payable Comparison

For the Biotechnology subindustry, Yarrow Bioscience's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Yarrow Bioscience Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Yarrow Bioscience's Days Payable distribution charts can be found below:

* The bar in red indicates where Yarrow Bioscience's Days Payable falls into.


YARW
13GF Score
Yarrow Bioscience Inc YARW
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Yarrow Bioscience Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Yarrow Bioscience's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

Days Payable (A: Dec. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: . 20 ) + Accounts Payable (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( ( + 1.534) / 1 ) / 0*365
=1.534 / 0*365
=N/A

Yarrow Bioscience's Days Payable for the quarter that ended in Jun. 2026 is calculated as:

Days Payable (Q: Jun. 2026 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Mar. 2026 ) + Accounts Payable (Q: Jun. 2026 )) / count ) / Cost of Goods Sold (Q: Jun. 2026 )*Days in Period
=( (0.912 + 0.614) / 2 ) / 0*365 / 4
=0.763 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
Yarrow Bioscience (YARW) has a Days Payable of 0.00 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Yarrow Bioscience and its competitors. According to the industry distribution chart, Yarrow Bioscience ranks #999999 out of 707 companies in the Biotechnology industry.
Is Yarrow Bioscience's Days Payable too high?
Yarrow Bioscience's current Days Payable is 0.00. Based on the distribution chart, Yarrow Bioscience ranks #999999 out of 707 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Yarrow Bioscience has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Yarrow Bioscience's Days Payable compare to CGTX and RANI?
According to the Biotechnology industry distribution chart, Yarrow Bioscience ranks #999999 out of 707 companies for Days Payable. This places Yarrow Bioscience in the lower half of its industry. The industry median Days Payable is 111.24. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 111.24, based on 707 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Yarrow Bioscience and its competitors. For the Biotechnology industry, the median Days Payable is 111.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Yarrow Bioscience's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yarrow Bioscience stock overvalued right now?
Yarrow Bioscience (YARW) has a current Days Payable of 0.00. The current Days Payable is 0.00. Yarrow Bioscience's overall GF Score™ is 13/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Yarrow Bioscience (YARW), the current Days Payable is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Yarrow Bioscience Business Description

Address 251 Little Falls Drive, County of New Castle, City of Wilmington, DE, USA, 19808
Yarrow Bioscience Inc is a clinical-stage biopharmaceutical company focused on developing biotherapeutics for autoimmune thyroid diseases. Its flagship product candidate, YB-101 (also known as GenSci098), is a humanized, monoclonal antibody targeting the thyroid-stimulating hormone receptor, which Yarrow plans to develop for the treatment of Graves' disease (GD) and potentially thyroid eye disease (TED). The company has one reportable segment relating to the research and development of its research programs, GD and TED.
13GF Score

Get the complete analysis for YARW

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$26.22
Price